Acknowledging the importance and humanitarian significance of the health care field, Minh Khang puts the the industry as one of the key business and development sectors. We strive to continuously learn and update new technologies. Our strategy is to focus on building complete solutions for testing, diagnosis, screening and eventually treatment, in hope of improving the quality of life and social welfare for all Vietnamese.
Minh Khang focuses on developing the full solutions for these applications:
- Newborn screening:
- G6PD Deficiency (Glucose-6-Phosphate Dehydrogenase Deficiency)
- Congenital Hypothyroidism (CH)
- Congenital Adrenal Hyperplasia (CAH)
- Inborn errors of metabolism
- Biotinidase Deficiency (BIOT)
- Galactosaemia (GALT)
- Cystic Fibrosis (CF)
- Severe Combined Immune Deficiency (SCID)
- Toxicology
- Occupational safety and Occupational diseases
- Lead exposure
- Benzene exposure
- Mercury poisoning
- Trinitrotoluene poisoning (TNT poisoning)
- Arsenic poisoning
- Green Tobacco Sickness (Nicotine exposure)
- Pesticide poisoning
- Cancer screening tests
- Genetic tests and molecular biomarkers
- Microbiology tests
- Covid 19 tests
Focus on applying the following analytical and testing technologies:
- Chromatography / Chromatography Mass Spectrometry: LCTQ, GCTQ, GCMS, HPLC
- Atomic Spectroscopy
- Molecular biology
- New generation gene sequencing
- Biochemical and immunological tests
- Stem cell therapy